In 2025, An AIIMS study assessed the performance of an Abbott CELL-DYN Ruby hematology analyzer. This unique study not only assessed the instrument performance, it assessed the performance of the quality specifications themselves. Which goals are most appropriate for hematology analyzers today?
A recent study looked at the analytical performance of a Sysmex XN-1000 in Karnataka, India. We benchmark the numbers against the CLIA 2025 guidelines.
A recent study looked at the analytical performance of three models of the Dymind hematology analyzer. If this laboratory was in the US, would they be able to meet CLIA 2025 targets?
A recent study looked at the analytical performance of a Roche cobas c501 at Phuc Hung General Hospital, Vietnam. Unfortunately, they made a mistake in their calculations. We provide the corrections here.
A study looked at the Sigma metrics across all three phases of the total testing process in a specialized hospital in Ethiopia. An interesting look at performance outside the usual setting.